Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France.
Phase of Trial: Phase III
Latest Information Update: 09 Jun 2013
At a glance
- Drugs Candesartan cilexetil (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms SISTOLA
- Sponsors AstraZeneca
- 12 Jul 2010 Actual end date changed from May 2009 to Jun 2010 as reported by ClinicalTrials.gov.
- 10 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jun 2008 New trial record.